Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation.
Holland EM, Molina JC, Dede K, Moyer D, Zhou T, Yuan CM, Wang HW, Stetler-Stevenson M, Mackall C, Fry TJ, Panch S, Highfill S, Stroncek D, Little L, Lee DW, Shalabi H, Yates B, Shah N.
Holland EM, et al.
J Immunother Cancer. 2022 May;10(5):e004483. doi: 10.1136/jitc-2021-004483.
J Immunother Cancer. 2022.
PMID: 35534047
Free PMC article.